https://www.marketscreener.com/quote/stock/EISAI-CO-LTD-6492461/news/Eisai-Metoject-Subcutaneous-Injection-Syringe-Methotrexate-Approved-in-Japan-for-Rheumatoid-Arthr-41860735/?utm_source=telegram&utm_medium=social&utm_campaign=share